Kazushige Kadota

Showing 1-14 of 14 articles

High Bleeding Risk and Clinical Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention: the PENDULUM Registry

Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y

July 7, 2020 | 10.4244/EIJ-D-20-00345

Coronary interventions

Impact of retrograde approach on long-term clinical outcomes of patients undergoing coronary chronic total occlusion interventions

Tanaka H, Ohya M, Kubo S, Miura K, Otsuru S, Habara S, Tada T, Fuku Y, Goto T, Kadota K

December 7, 2018 | 10.4244/EIJ-D-18-00534

Stents and scaffolds

Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT)

Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Nishikawa H, Kimura T

September 20, 2018 | 10.4244/EIJ-D-17-01050

Current use of intracoronary imaging in interventional practice – Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey

Koskinas K, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne R

July 20, 2018 | 10.4244/EIJY18M03_01

Coronary interventions

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone G, Popma J, Onuma Y, Serruys P, Kimura T

February 20, 2017 | 10.4244/EIJ-D-16-00359

Coronary interventions

Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDO-Kyoto AMI registry)

Watanabe H, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Kimura T

February 3, 2017 | 10.4244/EIJ-D-15-00421

Coronary interventions

Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Wöhrle J, Markovic S, Rottbauer W, Muramatsu T, Kadota K, Vázquez-González N, Odenstedt J, Serra A, Antoniucci D, Varenne O, Saito S, Wijns W

June 10, 2016 | 10.4244/EIJV12I2A30

Coronary interventions

Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice

Habara S, Kadota K, Kanazawa T, Ichinohe T, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K

February 19, 2016 | 10.4244/EIJY15M02_09

Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)

Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, Ino Y, Morino Y, Tanabe K, Kadota K, Kimura T

September 22, 2015 | 10.4244/EIJV11I5A109

Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure

Kubo S, Kadota K, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K

January 22, 2015 | 10.4244/EIJV10I9A180

Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions

Kubo S, Kadota K, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K

November 29, 2013 | 10.4244/EIJV9I7A131

Comparison of target-lesion revascularisation between left main coronary artery bifurcations and left anterior descending coronary artery bifurcations using the one and two stent approach with sirolimus-eluting stents

Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Okimoto T, Otsuka M, Tamekiyo H, Tamura T, Kadota K, Inoue K, Mitsudo K

November 30, 2011 | 10.4244/EIJV7I7A126

Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach

Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K

September 30, 2011 | 10.4244/EIJV7I5A95

Is there a higher risk of stent thrombosis in bifurcation lesion or is it related to the technique?

Iakovou I, Kadota K, Papamentzelopoulos S, Pavlides G, Mitsudo K

January 11, 2011

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Tetralogy of Fallot with acquired double right ventricular outflow tract

September 18, 2020

Device entrapment in chronic total occlusions

September 30, 2020

Complex PCI: time for a universal definition

Joanna J. Wykrzykowska

September 30, 2020

This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...

September 29, 2020

Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more

(Released thanks to the support of Biotronik)

September 30, 2020

Integrating physiology in OCT

September 23, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease